Episodi

  • Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer
    Apr 23 2026

    Are you confident in identifying the risk for recurrence in early-stage HR-positive, HER2-negative breast cancer?

    Credit available for this activity expires: [04/21/27]
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    26 min
  • Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence
    Apr 22 2026

    Risk vs Biology: Which carries more weight in the decision to escalate therapy?

    Credit available for this activity expires: 04/21/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/lessons-real-world-treating-high-risk-hr-her2-breast-cancer-2026a1000bhd?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    32 min
  • Beyond the Headlines: A Critical Look at MRA Evidence in HFpEF
    Apr 22 2026

    Are you up to date on the latest clinical developments for steroidal and nonsteroidal mineralocorticoid receptor antagonists (MRAs) in heart failure with preserved ejection fraction (HFpEF)?

    Credit available for this activity expires: 04/08/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-headlines-critical-look-mra-evidence-hfpef-2026a1000al7?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    29 min
  • Up Front Antibody-Drug Conjugates: Shifting the Paradigm in Metastatic Triple-Negative Breast Cancer Treatment
    Apr 9 2026

    Did you know that antibody-drug conjugates (ADCs) targeting Trop2 have demonstrated significant clinical potential for patients with TNBC?

    Credit available for this activity expires: 4/8/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/front-antibody-drug-conjugates-shifting-paradigm-metastatic-2026a1000a9z?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    39 min
  • Biosimilars: What Primary Care Needs to Know About Biosimilars in Practice
    Apr 8 2026

    Your patient asks, "Will switching to a biosimilar make my disease worse?" Learn how to confidently address their concerns.

    Credit available for this activity expires: 4/7/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003282?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    31 min
  • Enhancing Clinical Understanding of Oral SERD-Based Therapies for Patients With ER-Positive/HER2-Negative MBC
    Apr 8 2026

    Did you know prior CDK4/6 duration may be prognostic for identifying patients more likely to benefit from single-agent oral SERDs?

    Credit available for this activity expires: 04/07/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/enhancing-clinical-understanding-oral-serd-based-therapies-2026a1000a46?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    36 min
  • Maximizing Therapeutic Efficacy Prior to Epilepsy Surgery: Considerations for the Selection of Antiseizure Medications
    Apr 3 2026

    Optimize every trial: Discover how strategic medication selection clarifies the surgical path and improves patient outcomes before intervention.

    Credit available for this activity expires: 04/02/2027
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/maximizing-therapeutic-efficacy-prior-epilepsy-surgery-2026a10009oz?ecd=bdc_podcast_libsyn_mscpedu

    Mostra di più Mostra meno
    34 min
  • Expanding the Actionability of Crucial Biomarkers in Your Community-Based Colorectal Cancer Clinic
    Mar 30 2026

    Do you know what to test for in your patients with CRC?

    Credit available for this activity expires: 3/30/27
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/expanding-actionability-crucial-biomarkers-your-community-2026a10009al?ecd=bdc_podcast_libsyn_mscped

    Mostra di più Mostra meno
    30 min